Evidence map›Paper›PMID 33805599›Full record

ArticleMolecules (Basel, Switzerland)2021

Palatability Enhancement Potential of

David Terrey, Jack James, Ivan Tankovski, Monika Dalim, Michel van Spankeren, Arpita Chakraborty, Eric Schmitt, Aman Paul

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
4.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Protein hydrolysates fromAnimal cells and systems · 2025
    Article
  3. Article
  4. Unlocking the Real Potential of Black Soldier Fly (Molecules (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

David TerreyPontus Research Limited, Hirwaun CF44 9UP, UK.
Jack JamesPontus Research Limited, Hirwaun CF44 9UP, UK.
Ivan TankovskiPontus Research Limited, Hirwaun CF44 9UP, UK.
Monika DalimProtix B.V., 5107 NC Dongen, The Netherlands.
Michel van SpankerenProtix B.V., 5107 NC Dongen, The Netherlands.
Arpita ChakrabortyProtix B.V., 5107 NC Dongen, The Netherlands.
Eric SchmittProtix B.V., 5107 NC Dongen, The Netherlands.
Aman PaulProtix B.V., 5107 NC Dongen, The Netherlands.ORCID 0000-0002-2720-8368
Protix (Netherlands) · NLPontus Research · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marine feed ingredients derived from cephalopods (e.g., squid) and crustaceans (e.g., krill) are commercially used to improve the palatability of shrimp diets. Increase in global demand for shrimps has resulted in overfishing of these marine organisms and is a matter of concern. Insect protein hydrolysate could be a sustainable alternative for the possible replacement of these marine feed ingredients. During this study, four formulations: diet A (control: not containing any palatability enhancer), diet B (containing squid meal and krill oil), diet C (containing 1% insect protein hydrolysate), and diet D (containing 2% insect protein hydrolysate) were tested for (1) time required by first subject to begin feeding (time to strike) and (2) palatability in

Indexed as

Amino Acids, EssentialAnimal FeedAnimalsAquacultureArthropod ProteinsConservation of Natural ResourcesDecapodiformesDietDietary ProteinsDipteraEuphausiaceaFood PreferencesHumansInsect ProteinsLarvaPenaeidaeAmino Acids, EssentialArthropod ProteinsDietary ProteinsInsect ProteinsProtein Hydrolysatesfree amino acidsinsectLitopenaeus vannameipalatabilityprotein hydrolysateshort chain peptides

Identifiers

PMID33805599
PMCPMC8002068
OpenAlexW3137028851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.